{"nct_id":"NCT03138655","title":"Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)","status":"COMPLETED","status_verified_date":"2020-11","start_date":"2017-11-08","start_date_type":"ACTUAL","primary_completion_date":"2020-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2020-05-26","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}